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A Pilot Study of Audio-Visual Stimulation as a Self-Care Treatment for
Insomnia in Adults with Insomnia and Chronic Pain
Abstract
This pilot study tested the efficacy of an audio-visual stimulation (AVS) program for the promotion of sleep in
individuals with chronic pain. Insomnia and chronic pain are common comorbid conditions and their
relationship has been viewed as bidirectional. Recent studies suggest a relatively dominant role of sleep in this
dyad. The premise of this pilot study was that AVS enhances low frequency while reducing high frequency
brain activity resulting in decreased hyperarousal and improved sleep with potential consequent reduction in
pain. We conducted a pilot intervention study of AVS using a pre-post design. Participants self-administered a
30-min AVS program nightly at bedtime for 1 month. Sleep and pain were assessed at baseline and at the
conclusion of the 4-week intervention phase. Nine adults (mean age 33 ± 15.8 years; female, 89 %) completed
the study. After using the AVS device for 4 weeks, significant improvement was seen in reported insomnia
(ISI, p = 0.003), pain severity (BPI, p = 0.005), and pain interference with functioning (BPI, p = 0.001). Large
effect sizes (Partial η2 0.20-0.94) (Cohen's d 0.44-1.45) were observed. The results of this pilot study suggest
that the AVS program may be efficacious in decreasing both insomnia and pain symptoms. In order to better
assess the efficacy of AVS for sleep promotion and possible pain reduction, more definitive randomized
controlled trials will be needed. These should include appropriate sample sizes, objective measures of sleep
and pain, and longitudinal follow-up.
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Abstract
This pilot study tested the efficacy of an Audio-visual Stimulation (AVS) program for the 
promotion of sleep in individuals with chronic pain. Insomnia and chronic pain are common 
comorbid conditions and their relationship has been viewed as bidirectional. Recent studies 
suggest a relatively dominant role of sleep in this dyad. The premise of this pilot study was that 
AVS enhances low frequency while reducing high frequency brain activity resulting in decreased 
hyperarousal and improved sleep with potential consequent reduction in pain. We conducted a 
pilot intervention study of AVS using a pre-post design. Participants self-administered a 30-
minutes AVS program nightly at bedtime for one month. Sleep and pain were assessed at baseline 
and at the conclusion of the 4-week intervention phase. 9 adults (mean age 33 ± 15.8 years; 
female, 89%) completed the study. After using the AVS device for 4 weeks, significant 
improvement was seen in reported insomnia (ISI, p=.003), pain severity (BPI, p=.005), and pain 
interference with functioning (BPI, p=.001). Large effect sizes (Partial Eta2: .20–.94)(Cohen’s d: 
0.44–1.45) were observed. The results of this pilot study suggest that the AVS program may be 
efficacious in decreasing both insomnia and pain symptoms. In order to better assess the efficacy 
of AVS for sleep promotion and possible pain reduction, more definitive randomized controlled 
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trials will be needed. These should include appropriate sample sizes, objective measures of sleep 
and pain, and longitudinal follow-up.
Keywords
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Introduction
Chronic pain affects 1 in 3 Americans (Johannes, Le, Zhou, Johnston, & Dworkin, 2010), 
and 67–88% of adults with chronic pain experience some form of sleep disturbance (Morin, 
LeBlanc, Daley, Gregoire, & Merette, 2006). This striking level of comorbidity has 
suggested to many that the relationship between pain and sleep may be bi-directional 
(Alsaadi et al., 2014; Finan, Goodin, & Smith, 2013; Jansson-Frojmark & Boersma, 2012; 
McCracken & Iverson, 2002; Okifuji & Hare, 2011). That is, pain may serve to precipitate 
and perpetuate sleep continuity disturbance; and that sleep initiation and maintenance 
problems and/or sleep loss may serve to exacerbate or reduce the individual’s tolerance of 
chronic pain. Further, chronic insomnia may increase the risk for the development of other 
medical and psychiatric conditions (Matteson-Rusby, Pigeon, Gehrman, & Perlis, 2010) 
which, in turn, as comorbid conditions, increase the risk for the development, or 
exacerbation, of chronic pain. These issues, when taken together, strongly suggest that sleep 
disturbance, in the context of chronic pain, should be targeted for treatment.
Sleep and Chronic Pain
As noted above, the relationship between insomnia and chronic pain has been viewed as bi-
directional. Recent studies provide laboratory based evidence that individuals with primary 
insomnia and insomnia comorbid with chronic pain process pain abnormally (Haack et al., 
2012). For example, those with primary insomnia experienced spontaneous pain more 
frequently and intensely, exhibited a higher sensitivity to evoked heat and pressure pain, and 
had a dysfunctional pain inhibition system. These findings are consistent with the emerging 
hypothesis that insomnia is associated with increased pain perception and/or amplification. 
Importantly, findings from a recent systematic review show that sleep impairment not only 
predicts new onset and the continuation of chronic pain; sleep is a stronger predictor of 
chronic pain than chronic pain is to sleep impairment (Finan et al., 2013). This hypothesis is 
further supported by a longitudinal 13-year study in which sleep disturbances at baseline 
strongly predicted chronic or onset of radiating low back pain over the course of 
longitudinal follow up (Lusa, Miranda, Luukkonen, & Punakallio, 2014). Finally, results 
from a recent study show that short-term improvements in sleep predicted long-term 
improvements in chronic pain, insomnia symptoms, and fatigue (McCurry et al., 2014; 
Vitiello et al., 2014). Taken together these findings suggest that improving sleep might 
improve pain outcomes (Finan et al., 2013; M.T. Smith & Haythornthwaite, 2004; Turk & 
Cohen, 2010).
Current treatment options for sleep include pharmacological treatment and Cognitive 
Behavioral Therapy for Insomnia (CBT-I) (M. Perlis, Gehrman, & Riemann, 2008; Schutte-
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Rodin, Broch, Buysse, Dorsey, & Sateia, 2008). Medical treatment with hypnotics (e.g., 
benzodiazepines and benzodiazepine receptor agonists) has been shown to have good 
efficacy, safety, and durability for up to 12 months. Clinical benefits, however, do not 
persist after treatment discontinuation and some patients may experience loss of 
effectiveness and/or psychological dependence with extended use of hypnotics (Nowell et 
al., 1997; Roth, Walsh, Krystal, Wessel, & Roehrs, 2005). CBT-I is considered a gold 
standard non-pharmacological treatment, yielding treatment effects comparable to or 
exceeding those observed for medications (Jungquist et al., 2010b; Mitchell, Gehrman, 
Perlis, & Umscheid, 2012; M. T. Smith et al., 2002; Wang, Wang, & Tsai, 2005). Further, 
there is evidence that CBT-I for insomnia comorbid with chronic pain is as, or more, 
efficacious than when the treatment is applied to patients with “Primary Insomnia” 
(Jungquist et al., 2010a; Jungquist et al., 2012; Vitiello, Rybarczyk, Von Korff, & Stepanski, 
2009).
One area in insomnia research that has remained under studied is use of self-care approaches 
that people can use at the home setting to promote sleep. Specifically, brainwave 
entrainment through light and sound stimulation is an intervention that may have potential to 
promote relaxation and sleep, but its potential efficacy for improving sleep has not been well 
explored.
Audio-visual Stimulation (AVS)
The study of the Audio-visual Stimulation (AVS) can be traced back to 1930s. The term 
AVS is often used interchangeably with “light and sound stimulation” and “audio photic 
stimulation.” In 1934, with the availability of encephalogram, the impact of photic 
stimulation on brain activity was documented in a study in which increased brain activity 
was found to correspond to the frequency of a given photic stimulation (Adrian & Matthews, 
1934). During the following decade, several investigators reported brain activity changes in 
response to photic stimulation, noting that the rhythm of brain activity tended to assume the 
rhythm of the photic stimulus, which was termed “entrainment” (Bartley, 1937; Jasper, 
1936).
Brain activity AVS entrainment to slow frequencies to promote deep relaxation has been 
reported clinically and in several older studies. In 1980, one of the biofeedback/
neurofeedback pioneers, Dr. Thomas Budzynski reported using light and sound stimulation 
(stimulation frequency unspecified) to assist his clients in successfully achieving and 
maintaining theta state (3–6 Hz, pre Stage 1 sleep state) during psychotherapy sessions 
(Budzynski, 1992; Hutchison, 1990). A study by Harris demonstrated that light and sound 
stimulation (frequency undefined) promoted better sleep for his AIDS/HIV patients 
(Hutchison, 1990). In addition, a study by Hauri found that AVS closed-loop training, 
discussed further below, in the sensory motor rhythm (SMR, 12–15 Hz) promoted sleep in 
people who were physically relaxed but cognitively preoccupied (P. Hauri, 1981; P. J. 
Hauri, Percy, Hellekson, Hartmann, & Russ, 1982). Of note, Harris’ and Hauri’s studies are 
two of the few in the AVS literature that document an effect of AVS on sleep.
Audio-visual stimulation (AVS) is a promising self-care intervention option for insomnia 
that uses preprogrammed light and sound patterns to potentiate sleep-related EEG activity 
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(delta-theta 1–8 Hz) (Budzynski, Budzynski, Sherlin, & Tang, 2011). The AVS devices are 
inexpensive and readily available without a prescription. Although the AVS mechanism is 
not fully understood, it is thought that the auditory and visual elements of AVS stimulation 
modulate endogenous brain activity by activating retinal cells in the eyes and pressure-
sensitive cilia within the cochlea of the ears. The evoked electrical potential is then 
transmitted via neural pathways (audio signals via the medial geniculate; visual signals via 
the lateral geniculate) to the thalamus where audio and visual sensory information is 
processed. From the thalamus, the entrained electrical activity is propagated through the 
cortical thalamic loop to the rest of limbic system and the cerebral cortex (Budzynski et al., 
2011; Collura & Siever, 2008) (Figure 1). Importantly, reported adverse effects are minimal; 
the only known contraindication for adults is a history of a seizure disorder (Rodin, Daly, & 
Bickford, 1955). While the neural mechanism for AVS remains in debate, a study with six 
healthy adults demonstrated that repetitive training over a period of 2 months (25 sessions of 
AVS ramping from 18 down to 2 Hz over 20 minutes, with subjects laying in darkened room 
with eyes closed) significantly reduced beta and gamma activities and increased the theta/
alpha ratio (a brainwave state that is conducive for sleep onset). The findings suggested that 
with repeated training, AVS cultivates an adaptive self-regulation process and provides 
exogenous signals to entrain cortical activity to slower frequencies (Teplan, Krakovska, & 
Stolc, 2006, 2011).
One current line of thought about the ethology and pathophysiology of insomnia, is that 
chronic insomnia is a hybrid state (hyperarousal) wherein the subject is less disengaged from 
the environment owing to conditioned cortical arousal and/or local neuronal wakefulness 
(Buysse, Germain, Hall, Monk, & Nofzinger, 2011; M. L. Perlis, Giles, Mendelson, Bootzin, 
& Wyatt, 1997). This hypothesized state suggests that interventions that facilitate EEG 
slowing (via feedback, entrainment, conditioning, etc.) may promote improved sleep 
induction and maintenance. The purpose of this study was to examine the feasibility of a 30 
minutes self-administered AVS program for sleep promotion in adults with insomnia and 
chronic pain in the community setting.
Methods
This was a pilot intervention study using a pre- and post- design. Thirteen participants were 
recruited from the community sites in Philadelphia and Seattle, through flyers posted at 
community centers and advertisement placed in the local newspaper. Inclusion criteria were 
adults 21 years and older, having nonmalignant pain most days for more than 6 months, 
difficulty sleeping at least 3 nights per week for 3 months, a score of 8 or higher on the 
Insomnia Severity Index (ISI), and a score between 3 and 10 on the ‘worst pain’ item of the 
Brief Pain Inventory (BPI). Exclusion criteria were seizure disorder, night shift worker, 
known photosensitivity, cognitive impairment (assessed through in-person interview by 
trained research staff), severe psychiatric disorder, and history of a sleep disorder other than 
insomnia, such as restless leg syndrome, sleep apnea or narcolepsy. Sleep apnea was self-
reported or presumed based on a score higher than 0.5 on the Multivariate Apnea Prediction 
(MAP) index (Maislin et al., 1995). Restless Leg Syndrome was assessed with the 4 item 
simplified version of International Restless Legs Syndrome scale (IRLS)(Walters et al., 
2003; Wunderlich et al., 2005). This pilot study was approved by the University of 
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Pennsylvania and Seattle University Institutional Review Boards. Inform consent was 
obtained prior to data collection.
Measures
Insomnia Severity Index (ISI)—The ISI is a validated 7-item (0–4) scale that measures 
insomnia severity. Norms are: 0–7 = no clinically significant insomnia; 8–14 = sub threshold 
insomnia; 15–21 = clinical insomnia (moderate severity); 21–28 = clinical insomnia 
(severe). The ISI has internal consistency (alpha =0.90), sensitivity (86%) and specificity 
(87%); the scale is well-established and sensitive to changes with intervention (Bastien, 
Vallieres, & Morin, 2001; Morin, Belleville, Belanger, & Ivers, 2011).
Sleep diary—The diary is a two-page log with standard questions about the quantity and 
quality of the previous night of sleep, including Time to Bed, Sleep Latency, Number of 
Awakenings, Wake After Sleep Onset time (WASO), Total Sleep Time, and Time out of 
Bed. The diary also includes questions about the causes of sleep difficulties if any, caffeine 
and alcohol consumption, daytime napping, exercise, health issues, hypnotic use and the 
AVS adherence. The one-week sleep diary was completed once at baseline and again upon 
completion of the intervention.
Brief Pain Inventory (BPI)—The BPI (short form) is a 9-item assessment of pain 
severity, impact of pain on daily function, location of pain, pain medications and amount of 
pain relief in the past 24 hours. Administration takes 5 minutes. The scoring of the pain data 
yields 2 categories: 1) Pain Severity which is a combination of the four pain items (pain 
now, average pain, worst pain and least pain in the last 24 hours) [0=no pain, 10=pain as bad 
as you can imagine], and 2) Pain Interference with 7 daily activities/functioning including 
general activity, walking, work, mood, enjoyment of life, relations with others, and sleep 
[0=pain does not interferes, 10=pain completely interferes]. Reliability is adequate 
(Cronbach alpha = 0.77 – 0.91). The BPI has been tested in various pain conditions such as 
cancer pain, depressive disorders, fibromyalgia, osteoarthritis, etc. In addition, BPI is 
available in more than 36 languages and has been validated by confirming the consistency of 
its 2-factor structure (Cleeland & Ryan, 1994; Keller et al., 2004).
Patient Health Questionnaire (PHQ-9)—The PHQ-9 is a well-established scale 
measuring mood state. The items ask how often in the past 2 weeks the individual has been 
bothered by symptoms of depression. Scores on the PHQ-9 range from 0 to 27 (1–4 minimal 
depression; 5–9 mild depression; 10–14 moderate depression; 15–19 moderately severe 
depression; and 20–27 severe depression (Kroenke, Spitzer, & Williams, 2001).
Multivariable Apnea Prediction Index (MAP)—The MAP is a 13 items survey that 
screens for prediction of apnea. The survey assesses common symptoms of apnea such as 
loud snoring, gasping during sleep, breathing difficulty, and excessive daytime sleepiness. 
Participants were asked to rate the frequency of these identified symptoms on a numeric 
scale (0 = never; 4 = always, 5–7 times/week; and do not know). The score is then entered 
into a formula along with covariates (age, gender, and body mass index) for further 
computation. A MPA score higher than 0.5 suggests likelihood of sleep apnea (Maislin et 
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al., 1995). In this study, the MPA was assessed at the initial interview. People who scored 
higher than 0.5 on MPA were excluded from participating in this study.
International Restless Legs Syndrome scale (IRLS)—The IRLS (short form) is a 4 
item questionnaire that indexes typical symptoms of restless leg syndrome during the day 
and sleep (i.e., discomfort sensation in legs, urgency to move or rub legs to relieve 
discomfort, symptoms worsen when resting). The response option for each item is yes or no 
(Walters et al., 2003). The IRLS (short form) was used as a screening tool in this study. If a 
participant answered yes to all 4 questions, then they were not eligible to participate in this 
study.
Demographic data, brief health history (i.e., smoking, alcohol, drug use) and medication 
data (name, dosage, frequency, duration, indication, and medication changes) were also 
collected and used to describe the sample.
Procedure
At the initial meeting, participants completed the ISI, BPI, and PHQ-9 and were instructed 
to record their sleep patterns (sleep diary) for 1 week during the baseline period; which is a 
typical length of baseline observation in sleep research. After a 1-week baseline, they were 
trained to use the AVS program at bedtime and to record their sleep pattern in a sleep diary 
for 1 month. The AVS program [Procyon by MindPlace] consists of 30-minutes of light 
flickering (goggles) and sound pulsing (headphones) that gradually descends from alpha (8 
Hz) to delta (1 Hz) frequencies. Weekly phone calls were used to address participants’ 
questions and assess frequency of usage. The ISI, BPI, and PHQ-9 were measured again 
upon completion of the 1 month intervention.
Data Analysis
The raw data were screened for accuracy, missing values, outliers, and distributional 
properties prior to analysis (SPSS V21). The sample was characterized using descriptive 
statistics of demographic and baseline variables. Repeated paired sample T-tests were used 
to examine pre- and post- intervention differences. The effect size was examined using both 
ANOVA partial Eta2 and Cohen’s d.
Results
Thirteen adults were enrolled and nine (mean age 33±16, 89% women) (7 from Seattle, 2 
from Philadelphia) completed the study. Of the four participants who withdrew from the 
study, one reported sensitivity to the light stimulation even at the dimmest intensity, two did 
not like to wear any foreign object (goggles and ear buds) during sleep, and one declined to 
give a reason. None of the withdrawn participants reported serious adverse effects. There 
were no significant differences on the demographic characteristics and baseline measures 
between those who completed and those who withdrew.
Data were collected between November 2012 and March 2013. At baseline, the mean 
insomnia severity score (ISI) at was 19.2 ± 3.9, in the clinical insomnia moderate range. The 
total sleep time by self-reported sleep diary was 403.4 ± 70.2 minutes. Mean ratings for 
Tang et al. Page 6
Appl Psychophysiol Biofeedback. Author manuscript; available in PMC 2015 December 01.
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
N
IH
-P
A
 A
uthor M
anuscript
worst pain in the last 24 hours (7.0 ± 1.1), pain interference with sleep (8.0 ± 1.6), pain 
interference with the ability to enjoy life (5.4 ± 1.8), and the impact of pain on mood (5.2± 
2.3) were all elevated. The majority of the participants reported having back pain (67%); the 
rest reported pain that was disease related (i.e., congenital abdominal condition (11%), 
fibromyalgia (11%), and arthritis (11%). The mood measure (PHQ-9) at baseline was 11.9 ± 
5.6, in the moderate depression range.
After the one-month AVS intervention (with self-reported adherence to the AVS of 94%) 
significant improvement was observed for insomnia (ISI, p=.003). The sleep diary measures 
(sleep latency, WASO, total sleep time, and sleep efficiency), although not statistically 
significant, showed trends in the direction of improvement (Table 1). Before Bonferroni 
adjustment for multiple comparisons, significant improvement in pain severity (BPI, p=.
005), pain interference with daily functioning (BPI, p=.001), worst pain (BPI, p=.004), 
ability to sleep through pain (BPI, p=.015), pain interference with the mood (BPI, p=.012), 
the degree to which pain interfered with the enjoyment of life (BPI, p=.043), and depression 
(PHQ-9, p=.035) were observed. Thesefindings suggested large effect sizes (Partial Eta2, 
range 0.20–0.94)(Cohen’s d, range 0.44–1.45). When Bonferroni correction was performed, 
Insomnia Severity Index & BPI Pain Interference Functional remained statistically 
significant (Table 1).
Discussion
The results of this pilot study of a small sample with comorbid insomnia and pain suggest 
that the AVS program ramping from 8 to 1 Hz over the course of 30 minutes may be 
efficacious in decreasing insomnia symptoms. In addition to the positive changes in sleep, 
improvements were also observed in pain although pain was not directly treated. This result 
indirectly supports the emerging hypothesis that sleep may have a more prominent role than 
pain in the comorbid dyad (Finan et al., 2013) and illustrates the feasibility of this 
intervention approach.
Limitations
While the results of this preliminary study were encouraging, taking into account that sleep 
and pain are highly subjective phenomena, the interpretation of the findings is limited by the 
small sample size, lack of a control group, the lack of objective measures of sleep and pain, 
and the pre post design. In addition, the high self-reported adherence rate for AVS usage 
could be indicative of highly committed subjects or social desirability effects. To further the 
understanding of the AVS intervention in sleep promotion and pain reduction, we 
recommend that future study include a randomized controlled design with a larger sample 
size, an objective measure of sleep and pain, and longitudinal follow up.
Implications
This pilot study is the first to examine the efficacy of a 30 minutes self-administered 
portable in-home AVS self-care intervention for sleep induction in adults with chronic pain. 
Considering that treatment options for insomnia are somewhat limited, AVS could serve as 
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an initial intervention in a stepped care approach for the management of insomnia in people 
with chronic pain.
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Figure 1. 
AVS Auditory and Visual Pathways
In AVS, the visual stimulation (flickering light) is delivered through goggles with light-
emitting diodes (LEDs) and the audio stimulation is delivered through headphones.
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